Physician profile
Thomas A Salzer
NPI 1558315739
$1,663.29
in general payments reported to CMS, 2019-2025
14 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $206 · 2021: $207 · 2022: $178 · 2023: $202 · 2024: $192 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $804.90 | 2019-2022 | |
| Genzyme Corporation | $266.84 | 2022-2025 | |
| Glaxosmithkline, LLC. | $126.60 | 2023 | Nucala |
| Tela Bio, INC. | $77.60 | 2021-2022 | |
| Optinose US, INC. | $65.62 | 2019-2025 | |
| Wound Management Technologies, INC | $60.07 | 2019 | |
| Integra Lifesciences Corporation | $52.30 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $49.56 | 2025 | |
| Medtronic, INC. | $36.98 | 2022-2023 | Propel |
| Inspire Medical Systems, INC. | $32.29 | 2023 | Inspire |
| Regeneron Healthcare Solutions, INC. | $26.26 | 2020 | |
| Fisher & Paykel Healthcare INC | $25.71 | 2023 | Fisher & Paykel Healthcare |
| Ars Pharmaceuticals Operations, INC. | $23.65 | 2025 | Neffy |
| Arbor Pharmaceuticals, INC. | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Salzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.